Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Platelet to lymphocyte ratio is associated with contrast induced nephropathy after primary percutaneous coronary intervention for ST-elevation myocardial infarction section

Eser Acikgoz, Sadik Kadri Acikgoz, Gokhan Cicek.




Abstract
Cited by 1 Articles

Aim: Platelet to lyphocyte ratio is a novel inflammatory marker which is correlated with markers such as C-reactive protein and associated with cardiovascular outcomes in coronary artery disease. Contrast iduced nephropathy is an important complication of pecutaneous coronary intervention. Association between platelet to lymphocyte ratio and contrast induced nephropathy development after primary percutaneous coronary intervention with a diagnosis of ST-elevation myocardial infarction was evaluated in this study.
Material and Methods: Data of 3352 consecutive patients who underwent primary percutaneous coronary intervention for ST-elevation myocardial infarction were analysed. Independent predictors of contrast induced nephropathy were investigated with logistic regression analysis.
Results: Patients with contrast induced nephropathy had significantly higher platelet to lymphocyte ratio (150.0 vs 119.1, p=0.001).In multivariate logistic regression analysis platelet to lymphocyte ratio (OR 1.100, 95% CI 1.050-1.130, p=0.033) was found as an independent predictor of contrast induced nephropathy.
Conclusion: Platelet to lymphocyte ratio may have a role to predict contrast induced nephropathy in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.

Key words: Contrast Induced Nephropathy; ST-Elevation Myocardial Infarction; Primary Percutaneous Coronary Intervention.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.